Hikma Pharmaceuticals Plc Holding(s) in Company (3666S)

TIDMHIK

RNS Number : 3666S

Hikma Pharmaceuticals Plc

20 December 2016

 
 For filings with the FCA 
  include the annex 
 For filings with issuer exclude 
  the annex 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
--------------------------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                            Hikma Pharmaceuticals PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
------------------------------------------------------  ------------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
--------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
------------------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------------------------------  ------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------------------------------  ------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------------------  ------- 
 Other (please                                          New issued share capital affected    ü 
  specify):                                             existing holding percentage 
-----------------------------------------------------  -----------------------------------  ------- 
 3. Full name of person(s)                               Darhold Limited 
  subject to the 
  notification obligation: 
  (iii) 
------------------------------------------------------  ------------------------------------------- 
 4. Full name of shareholder(s)                          Darhold Limited 
  (if different from 3.):(iv) 
------------------------------------------------------  ------------------------------------------- 
 5. Date of the transaction                              19 December 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
------------------------------------------------------  ------------------------------------------- 
 6. Date on which issuer                                 19 December 2016 
  notified: 
------------------------------------------------------  ------------------------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                     25% 
------------------------------------------------------  ------------------------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type      Situation previous                  Resulting situation after the 
  of              to the triggering                   triggering transaction 
  shares          transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
--------------  ----------------------------------  ------------------------------------------------------------------ 
                 Number            Number            Number          Number of                    % of voting 
                  of                of                of shares       voting                       rights (x) 
                  Shares            Voting                            rights 
                                    Rights 
--------------  ----------------  ----------------  --------------  ---------------------------  --------------------- 
                                                     Indirect        Direct         Indirect      Direct    Indirect 
                                                                      (xi)           (xii) 
--------------      ------------    ------------    --------------  -------------  ------------  --------  ----------- 
 
 
  GB00B0LCW083                                       60,000,000      60,000,000     0             25.00%    0 
                                                    --------------  -------------  ------------  --------  ----------- 
                 59,909,270        59,909,270 
--------------  ----------------  ----------------  ------------      -----------  ------------  --------    --------- 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of financial   Expiration      Exercise/                         Number of voting           % of voting 
  instrument          date            Conversion                        rights that                rights 
                      (xiii)          Period (xiv)                      may be 
                                                                        acquired if 
                                                                        the 
                                                                        instrument 
                                                                        is 
                                                                        exercised/ 
                                                                        converted. 
------------------  --------------  --------------------------------  -------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of           Exercise        Expiration      Exercise/       Number of voting               % of voting 
 financial          price          date            Conversion       rights instrument              rights (xix, 
 instrument                        (xvii)          period           refers to                      xx) 
                                                   (xviii) 
----------------  --------------  --------------  --------------  -----------------------------  --------------------- 
                                                                                                  Nominal     Delta 
----------------  --------------  --------------  --------------  -----------------------------  ----------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                                           Percentage of voting rights 
----------------------------------------------------------------  ---------------------------------------------------- 
 60,000,000                                                        25.00% 
----------------------------------------------------------------  ---------------------------------------------------- 
 
 
   9. Chain of controlled undertakings through which the 
   voting rights and/or the 
   financial instruments are effectively held, if applicable: 
   (xxi) 
---------------------------------------------------------------------------------------------------------------------- 
 N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                                      N/A 
---------------------------------------------------------------------------------  ----------------------------------- 
 11. Number of voting rights proxy holder 
  will acquire:                                                                     0 
---------------------------------------------------------------------------------  ----------------------------------- 
 12. Date on which proxy holder will                                                N/A 
  acquire voting rights: 
---------------------------------------------------------------------------------  ----------------------------------- 
 
 
  13. Additional information: 
----------------------------------------------------------------  ---------------------------------------------------- 
 14. Contact name:                                                 Peter Speirs, Company Secretary 
                                                                    of Hikma Pharmaceuticals 
                                                                    PLC 
----------------------------------------------------------------  ---------------------------------------------------- 
 15. Contact telephone number:                                     [phone] 
----------------------------------------------------------------  ---------------------------------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLURVRRNNAUUAA

(END) Dow Jones Newswires

December 20, 2016 06:00 ET (11:00 GMT)